| Literature DB >> 10076575 |
Y Matsumura1, M Yokoyama, K Kataoka, T Okano, Y Sakurai, T Kawaguchi, T Kakizoe.
Abstract
For intravenous (i.v.) injection of a water-insoluble antitumor drug, KRN5500, we have successfully incorporated KRN5500 into polymeric micelles. In the present study, in vitro and in vivo anti-tumor activity against several human tumor cell lines and toxicity in mice of polymeric micelles incorporating KRN5500 (KRN/m) were evaluated in comparison with those of the prototype KRN5500. KRN/m was found to express similar antitumor activity to KRN5500 in the in vitro and in vivo systems. However, the vascular damage and liver focal necrosis observed with KRN5500 i.v. injection were not seen when KRN/m was administered i.v. Therefore, we expect that KRN/m will be superior to KRN5500 for clinical use and that the methodology of polymeric micelle drug carrier systems can be applied to other water-insoluble drugs.Entities:
Mesh：
Substances：
Year: 1999 PMID： 10076575 PMCID： PMC5925985 DOI： 10.1111/j.1349-7006.1999.tb00675.x
Source DB: PubMed Journal: Jpn J Cancer Res ISSN： 0910-5050